 Connection
Sarah Rowan to HIV Infections
This is a "connection" page, showing publications Sarah Rowan has written about HIV Infections.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
2.088 |
|
|
|
-
Haukoos J, Faryar K, Rowan S. Human Immunodeficiency Virus Pre-Exposure Prophylaxis: The Next Wave in Emergency Department-Based Human Immunodeficiency Virus Prevention. Ann Emerg Med. 2023 04; 81(4):482-484.
Score: 0.288
-
Rowan SE, Patel RR, Schneider JA, Smith DK. Same-day prescribing of daily oral pre-exposure prophylaxis for HIV prevention. Lancet HIV. 2021 02; 8(2):e114-e120.
Score: 0.250
-
Rowan SE, Kamis KF, Beum R, Bryan K, Gawenus L, Colon Sanchez D, Hurley H. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program. J Infect Dis. 2020 09 02; 222(Suppl 5):S384-S391.
Score: 0.247
-
Haukoos JS, Rowan SE. Screening for HIV infection. BMJ. 2016 Jan 19; 532:i1.
Score: 0.179
-
Rowan SE, Burman WJ, Johnson SC, Connick E, Reirden D, Daniloff E, Gardner EM. Engagement-in-care during the first 5 years after HIV diagnosis: data from a cohort of newly HIV-diagnosed individuals in a large US city. AIDS Patient Care STDS. 2014 Sep; 28(9):475-82.
Score: 0.162
-
Meyers K, Lane B, Zucker J, Wu Y, Carnevale C, Burnside H, Rowan S, Mayes E, Narcisse-Cempini G, Gold MA, Saldana L, Golub SA. A case study of the co-creation of the PrEP-SIC: a roadmap to support introduction of pre-exposure prophylaxis into new settings. BMC Health Serv Res. 2025 May 01; 25(1):631.
Score: 0.085
-
Toerper MF, Haukoos J, Hopkins E, Rowan SE, Lyons MS, Galbraith JW, Hsieh YH, White DA, Levin S, Hinson J, Rothman RE. Use of Epic? to facilitate high-quality randomization of emergency department-based pragmatic clinical trials. Clin Trials. 2025 Apr; 22(2):142-151.
Score: 0.083
-
Haukoos J, Hopkins E, Campbell JD, Lyons MS, Rothman RE, Hsieh YH, White DAE, Trent S, Al-Tayyib AA, Gardner EM, Sabel AL, Rowan SE. Cost-Effectiveness of HIV Screening in Emergency Departments: Results From the Pragmatic Randomized HIV Testing Using Enhanced Screening Techniques in Emergency Departments Trial. Ann Emerg Med. 2024 Sep; 84(3):234-243.
Score: 0.080
-
Lovett A, Luder R, Lillis RA, Butler I, Siren J, Gomez S, Kamis K, Obafemi O, Rowan SE, Baral S, Clement ME. Client Perspectives on the Development of a Rapid PrEP Initiative at a Sexual Health Center in New Orleans, Louisiana. J Int Assoc Provid AIDS Care. 2024 Jan-Dec; 23:23259582241258559.
Score: 0.078
-
Brooks KM, Castillo-Mancilla JR, Morrow M, Mawhinney S, Rowan SE, Wyles D, Blum J, Huntley R, Salah L, Tehrani A, Jimmerson LC, Roon L, Bushman LR, Anderson PL, Kiser JJ. Predictors of 007 triphosphate concentrations in dried blood spots in persons with hepatitis C and active drug or alcohol use. J Antimicrob Chemother. 2022 04 27; 77(5):1396-1403.
Score: 0.069
-
Kamis KF, Barbera L, Abdo M, Rowan SE, Hussain C, Gardner EM, Johnson SC, MaWhinney S, Davis AJ, Carlson J, Kozacka KA, Erlandson KM. Risk Factors for Hospitalization in People With HIV and COVID-19. J Acquir Immune Defic Syndr. 2021 11 01; 88(3):e22.
Score: 0.067
-
Haukoos JS, White DAE, Rowan SE, Lyle C, Gravitz S, Basham K, Godoy A, Kamis K, Hopkins E, Anderson E. Development of a 2-step algorithm to identify emergency department patients for HIV pre-exposure prophylaxis. Am J Emerg Med. 2022 01; 51:6-12.
Score: 0.067
-
Barbera LK, Kamis KF, Rowan SE, Davis AJ, Shehata S, Carlson JJ, Johnson SC, Erlandson KM. HIV and COVID-19: review of clinical course and outcomes. HIV Res Clin Pract. 2021 08; 22(4):102-118.
Score: 0.066
-
Haukoos JS, Lyons MS, Rothman RE, White DAE, Hopkins E, Bucossi M, Ruffner AH, Ancona RM, Hsieh YH, Peterson SC, Signer D, Toerper MF, Saheed M, Pfeil SK, Todorovic T, Al-Tayyib AA, Bradley-Springer L, Campbell JD, Gardner EM, Rowan SE, Sabel AL, Thrun MW. Comparison of HIV Screening Strategies in the Emergency Department: A Randomized Clinical Trial. JAMA Netw Open. 2021 07 01; 4(7):e2117763.
Score: 0.065
-
Haukoos JS, White DAE, Rowan SE, Lyle C, Gravitz S, Basham K, Godoy A, Kamis K, Hopkins E, Anderson E. HIV Risk and Pre-Exposure Prophylaxis Eligibility Among Emergency Department Patients. AIDS Patient Care STDS. 2021 06; 35(6):211-219.
Score: 0.065
-
Brooks KM, Castillo-Mancilla JR, Morrow M, MaWhinney S, Blum J, Wyles DL, Rowan SE, Ibrahim ME, Zheng JH, Johnson B, Gomez J, Choi YJ, Cendali F, Haas H, Roon L, Bushman LR, Anderson PL, Kiser JJ. Pharmacokinetics and renal safety of tenofovir alafenamide with boosted protease inhibitors and ledipasvir/sofosbuvir. J Antimicrob Chemother. 2020 11 01; 75(11):3303-3310.
Score: 0.062
-
Hawkins KL, Montague BT, Rowan SE, Beum R, McLees MP, Johnson S, Gardner EM. Boosted darunavir and dolutegravir dual therapy among a cohort of highly treatment-experienced individuals. Antivir Ther. 2019; 24(7):513-519.
Score: 0.055
-
Bhatia R, Modali L, Lowther M, Glick N, Bell M, Rowan S, Keglovitz K, Schneider J. Outcomes of Preexposure Prophylaxis Referrals From Public STI Clinics and Implications for the Preexposure Prophylaxis Continuum. Sex Transm Dis. 2018 01; 45(1):50-55.
Score: 0.051
-
Rowan SE, Rogers M, Bayer J, Smith L, Gardner EM, Johnson S, Langness J. Treatment of Hepatitis C Virus in HIV-Coinfected Individuals in Real-world Clinical Settings: Results From 2 Large HIV Care Clinics. Clin Infect Dis. 2016 10 01; 63(7):994-5.
Score: 0.046
-
Bianchini ML, Rowan SE, Frost HM, Valuck R, McQueen RB, Anderson HD. Trends in Demographic Characteristics and Risk Factors Among Individuals With Syphilis in Colorado From 2011 to 2020. Sex Transm Dis. 2025 Jun 01; 52(6):345-351.
Score: 0.021
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|